Week 1: | Â | Vincristine 0.7 mg/m2 IV |
---|---|---|
 |  | Asparaginase 400 IU/kg IM |
 |  | Pre-med with chlorphenamine: small-medium 2.5- |
 |  | 5 mg IM; medium-large 5-10 mg IM |
 |  | Prednisolone 2 mg/kg PO SID |
 | Start antacids: | zantac 2 mg/kg PO BID |
 |  | antepsin < 20 kg 500 mg, > 20 kg 1-2 g PO TID |
Week 2: | Â | Cyclophosphamide 250 mg/m2 PO or IV (+ NaCl) |
 |  | Prednisolone 1.5 mg/kg PO SID |
 | Stop antacids: | after week 2 |
Week 3: | Â | Vincristine 0.7 mg/m2 IV |
 |  | Prednisolone 1 mg/kg PO SID |
Week 4: | Â | Doxorubicin 30 mg/m2 IV (+ 0.9% NaCl) |
 |  | Pre-med with chlorphenamine and |
 |  | metoclopramide 0.5-1 mg/kg IM/SC) |
 |  | Prednisolone 0.5 mg/kg PO SID |
Week 6: | Â | Vincristine 0.7 mg/m2 IV |
Week 7: | Â | Cyclophosphamide 250 mg/m2 PO or IV (+ NaCl) |
Week 8: | Â | Vincristine 0.7 mg/m2 IV |
Week 9: | Â | Doxorubicin 30 mg/m2 IV (+ 0.9% NaCl) Pre-med with chlorphenamine + metoclopramide |
Week 11: | Â | Vincristine 0.7 mg/m2 IV |
Week 13: | Â | Cyclophosphamide 250 mg/m2 PO or IV (+ NaCl) |
Week 15: | Â | Vincristine 0.7 mg/m2 IV |
Week 17: | Â | Doxorubicin 30 mg/m2 IV (+ 0.9% NaCl) Pre-med with chlorphenamine + metoclopramide |
Week 19: | Â | Vincristine 0.7 mg/m2 IV |
Week 21: | Â | Cyclophosphamide 250 mg/m2 PO or IV (+ NaCl) |
Week 23: | Â | Vincristine 0.7 mg/m2 IV |
Week 25: | Â | Doxorubicin 30 mg/m2 IV (+ 0.9% NaCl) Pre-med with chlorphenamine + metoclopramide |